Global Niraparib
Market Report
2025
Delivery Includes:- Market Timeline 2021 till 2033, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Niraparib Market Report 2025.
"Global Niraparib market size 2025 is $1650.2 Million whereas according out published study it will reach to $3192.83 Million by 2033. Niraparib market will be growing at a CAGR of 8.6% during 2025 to 2033."
As per the current market study, out of 1650.2 Million USD global market revenue 2025, North America market holds 26.70% of the market share. The North America Niraparib industry grew from 320.318 Million USD in 2021 to 440.603 Million USD in 2025 and will record 72.70% growth. In coming future this industry will reach 846.099 Million by 2033 with a 8.498% CAGR. If we look at the percentage market shares of top North America countries for 2025,United States (82.10%), Canada (15.10%), Mexico (2.80%)
As per the current market study, out of 1650.2 Million USD global market revenue 2025, Europe market holds 23.50% of the market share. The Europe Niraparib industry grew from 281.168 Million USD in 2021 to 387.797 Million USD in 2025 and will record 72.50% growth. In coming future this industry will reach 737.543 Million by 2033 with a 8.367% CAGR. If we look at the percentage market shares of top Europe countries for 2025,United Kingdom (15.80%), Germany (19.60%), France (14.00%), Italy (9.80%), Russia (13.00%), Spain (7.60%), Sweden (2.00%), Denmark (1.80%), Switzerland (2.60%), Luxembourg (1.50%), Rest of Europe (12.30%)
As per the current market study, out of 1650.2 Million USD global market revenue 2025, Asia Pacific market holds 38.20% of the market share. The Asia Pacific Niraparib industry grew from 449.631 Million USD in 2021 to 630.376 Million USD in 2025 and will record 71.33% growth. In coming future this industry will reach 1242.01 Million by 2033 with a 8.847% CAGR. If we look at the percentage market shares of top Asia Pacific countries for 2025,China (44.20%), Japan (10.50%), India (16.50%), South Korea (5.60%), Australia (2.90%), Singapore (1.40%), South East Asia (7.80%), Taiwan (2.70%), Rest of APAC (9.68%)
As per the current market study, out of 1650.2 Million USD global market revenue 2025, South America market holds 3.81% of the market share. The South America Niraparib industry grew from 48.641 Million USD in 2021 to 62.917 Million USD in 2025 and will record 77.31% growth. In coming future this industry will reach 114.942 Million by 2033 with a 7.824% CAGR. If we look at the percentage market shares of top South America countries for 2025,Brazil (41.20%), Argentina (16.30%), Colombia (12.20%), Peru (8.00%), Chile (7.60%), Rest of South America (14.70%)
As per the current market study, out of 1650.2 Million USD global market revenue 2025, Middle East market holds 4.60% of the market share. The Middle East Niraparib industry grew from 52.2 Million USD in 2021 to 75.909 Million USD in 2025 and will record 68.77% growth. In coming future this industry will reach 156.448 Million by 2033 with a 9.461% CAGR. If we look at the percentage market shares of top Middle East countries for 2025,Saudi Arabia (21.00%), Turkey (20.60%), UAE (18.00%), Egypt (14.00%), Qatar (6.10%), Rest of Middle East (20.30%)
As per the current market study, out of 1650.2 Million USD global market revenue 2025, Africa market holds 3.19% of the market share. The Africa Niraparib industry grew from 34.405 Million USD in 2021 to 52.597 Million USD in 2025 and will record 65.41% growth. In coming future this industry will reach 95.785 Million by 2033 with a 7.781% CAGR. If we look at the percentage market shares of top Africa countries for 2025,Nigeria (22.50%), South Africa (42.10%), Rest of Africa (35.40%)
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Niraparib Market Sales Revenue | $ 1186.36 Million | $ 1650.2 Million | $ 3192.83 Million | 8.6% |
North America Niraparib Market Sales Revenue | $ 320.318 Million | $ 440.603 Million | $ 846.099 Million | 8.498% |
United States Niraparib Market Sales Revenue | $ 263.622 Million | $ 361.735 Million | $ 692.109 Million | 8.448% |
Canada Niraparib Market Sales Revenue | $ 49.009 Million | $ 66.531 Million | $ 125.223 Million | 8.226% |
Mexico Niraparib Market Sales Revenue | $ 7.688 Million | $ 12.337 Million | $ 28.767 Million | 11.163% |
Europe Niraparib Market Sales Revenue | $ 281.168 Million | $ 387.797 Million | $ 737.543 Million | 8.367% |
United Kingdom Niraparib Market Sales Revenue | $ 45.268 Million | $ 61.272 Million | $ 114.319 Million | 8.108% |
Germany Niraparib Market Sales Revenue | $ 55.671 Million | $ 76.008 Million | $ 142.346 Million | 8.158% |
France Niraparib Market Sales Revenue | $ 39.926 Million | $ 54.292 Million | $ 101.781 Million | 8.172% |
Italy Niraparib Market Sales Revenue | $ 28.398 Million | $ 38.004 Million | $ 70.804 Million | 8.088% |
Russia Niraparib Market Sales Revenue | $ 37.114 Million | $ 50.414 Million | $ 94.405 Million | 8.157% |
Spain Niraparib Market Sales Revenue | $ 22.493 Million | $ 29.473 Million | $ 54.578 Million | 8.007% |
Sweden Niraparib Market Sales Revenue | $ 6.467 Million | $ 7.756 Million | $ 12.538 Million | 6.188% |
Denmark Niraparib Market Sales Revenue | $ 5.623 Million | $ 6.98 Million | $ 11.063 Million | 5.925% |
Switzerland Niraparib Market Sales Revenue | $ 7.873 Million | $ 10.083 Million | $ 16.963 Million | 6.719% |
Luxembourg Niraparib Market Sales Revenue | $ 4.78 Million | $ 5.817 Million | $ 9.588 Million | 6.446% |
Rest of Europe Niraparib Market Sales Revenue | $ 27.554 Million | $ 47.699 Million | $ 109.156 Million | 10.903% |
Asia Pacific Niraparib Market Sales Revenue | $ 449.631 Million | $ 630.376 Million | $ 1242.01 Million | 8.847% |
China Niraparib Market Sales Revenue | $ 197.838 Million | $ 278.626 Million | $ 553.936 Million | 8.969% |
Japan Niraparib Market Sales Revenue | $ 49.01 Million | $ 66.19 Million | $ 127.927 Million | 8.585% |
India Niraparib Market Sales Revenue | $ 72.84 Million | $ 104.012 Million | $ 208.658 Million | 9.092% |
South Korea Niraparib Market Sales Revenue | $ 26.079 Million | $ 35.301 Million | $ 65.826 Million | 8.1% |
Australia Niraparib Market Sales Revenue | $ 14.838 Million | $ 18.281 Million | $ 31.05 Million | 6.846% |
Singapore Niraparib Market Sales Revenue | $ 7.194 Million | $ 8.825 Million | $ 16.146 Million | 7.843% |
South East Asia Niraparib Market Sales Revenue | $ 35.971 Million | $ 49.169 Million | $ 93.151 Million | 8.314% |
Taiwan Niraparib Market Sales Revenue | $ 13.489 Million | $ 17.02 Million | $ 32.292 Million | 8.335% |
Rest of APAC Niraparib Market Sales Revenue | $ 39.883 Million | $ 61.05 Million | $ 131.083 Million | 10% |
South America Niraparib Market Sales Revenue | $ 48.641 Million | $ 62.917 Million | $ 114.942 Million | 7.824% |
Brazil Niraparib Market Sales Revenue | $ 19.943 Million | $ 25.922 Million | $ 47.701 Million | 7.921% |
Argentina Niraparib Market Sales Revenue | $ 8.074 Million | $ 10.255 Million | $ 18.391 Million | 7.573% |
Colombia Niraparib Market Sales Revenue | $ 6.129 Million | $ 7.676 Million | $ 13.678 Million | 7.488% |
Peru Niraparib Market Sales Revenue | $ 3.989 Million | $ 5.033 Million | $ 9.08 Million | 7.654% |
Chile Niraparib Market Sales Revenue | $ 3.794 Million | $ 4.782 Million | $ 8.391 Million | 7.282% |
Rest of South America Niraparib Market Sales Revenue | $ 6.712 Million | $ 9.249 Million | $ 17.701 Million | 8.452% |
Middle East Niraparib Market Sales Revenue | $ 52.2 Million | $ 75.909 Million | $ 156.448 Million | 9.461% |
Saudi Arabia Niraparib Market Sales Revenue | $ 10.805 Million | $ 15.941 Million | $ 33.089 Million | 9.558% |
Turkey Niraparib Market Sales Revenue | $ 10.858 Million | $ 15.637 Million | $ 32.072 Million | 9.394% |
UAE Niraparib Market Sales Revenue | $ 9.292 Million | $ 13.664 Million | $ 28.63 Million | 9.687% |
Egypt Niraparib Market Sales Revenue | $ 7.412 Million | $ 10.627 Million | $ 21.449 Million | 9.175% |
Qatar Niraparib Market Sales Revenue | $ 3.341 Million | $ 4.63 Million | $ 9.387 Million | 9.235% |
Rest of Middle East Niraparib Market Sales Revenue | $ 10.492 Million | $ 15.41 Million | $ 31.822 Million | 9.488% |
Africa Niraparib Market Sales Revenue | $ 34.405 Million | $ 52.597 Million | $ 95.785 Million | 7.781% |
Nigeria Niraparib Market Sales Revenue | $ 7.672 Million | $ 11.834 Million | $ 21.695 Million | 7.871% |
South Africa Niraparib Market Sales Revenue | $ 14.622 Million | $ 22.143 Million | $ 39.942 Million | 7.652% |
Rest of Africa Niraparib Market Sales Revenue | $ 12.11 Million | $ 18.619 Million | $ 34.147 Million | 7.876% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type |
|
Market Split by Application |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Niraparib industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Niraparib Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Market Dynamics such as Drivers, Restraints, Opportunities, Trends data
The pharmaceutical and healthcare industry is expanding rapidly, driven by an aging global population, increasing prevalence of chronic diseases, and rising healthcare expenditure. Investments in precision medicine, gene therapy, and digital health are reshaping the industry, improving patient outcomes and reducing costs.
However, the industry faces challenges such as high drug development costs, strict regulatory requirements, and pricing pressures. Despite these challenges, emerging markets in Asia-Pacific, Latin America, and the Middle East offer significant growth opportunities, driven by improving healthcare infrastructure and rising disposable income.
Key trends shaping the industry include the adoption of artificial intelligence (AI) and machine learning (ML) for personalized medicine, telemedicine, and digital health. Sustainability and eco-friendly pharmaceutical solutions are also gaining traction, driven by regulatory demands for greater environmental responsibility.
We have various report editions of Niraparib Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.
The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.
Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.
Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.
Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.
The pharmaceutical and healthcare industry is highly competitive, with key players expanding their portfolios through new product launches, mergers and acquisitions, strategic partnerships, and regulatory approvals.
Financial performance metrics include revenue, gross margin, and market share, as well as SWOT analysis for key players. The report also evaluates companies' responses to COVID-19 challenges, including supply chain adjustments and investments in digital healthcare solutions.
The market size is projected based on global, regional, and country-level demand patterns, with research including value chain analysis, patent analysis, and competitive matrix. This comprehensive study serves as a vital resource for investors, industry stakeholders, and businesses navigating the evolving pharmaceutical and healthcare landscape.
Top Companies Market Share in Niraparib Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Region and country analysis section of Niraparib Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.
The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Niraparib market.
The current report Scope analyzes Niraparib Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Niraparib Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Niraparib Industry growth. Niraparib market has been segmented with the help of its Type, Application , and others. Niraparib market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
This report categorizes competitors in the pharmaceutical and healthcare market based on their product offerings and business models. It includes key details such as definitions, benefits, applications, technological advancements, and regional advantages for each type of pharmaceutical product, including small molecule drugs, biologics, and biosimilars.
Market growth figures, such as market share percentages, revenue, and growth rates (e.g., CAGR), are provided for each segment over the specified period (2019-2023). The report covers various segments
Type of Niraparib analyzed in this report are as follows:
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Niraparib Industry. Request a Free Sample PDF!
This report analyzes revenue growth in the pharma and healthcare industry at global, regional, and national levels, highlighting trends and opportunities for each application. It explores how sectors like pharmaceuticals, therapy, and healthcare monitoring use innovations to address healthcare needs. Key factors include market size, revenue contributions, technological advancements (e.g., AI-driven diagnostics), and regulatory considerations. The report also covers the value chain, identifying key players and processes within the industry. For more information, please request a sample or contact our research team.
Some of the key Application of Niraparib are:
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Niraparib Market is witnessing significant growth in the near future.
In 2023, the 100mg*30 Capsules segment accounted for noticeable share of global Niraparib Market and is projected to experience significant growth in the near future.
The Recurrent Epithelial Ovarian Cancer segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies TESARO , and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | 100mg*30 Capsules, 100mg*60 Capsules, 100mg*90 Capsules |
Application | Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Other |
List of Competitors | TESARO, Everest Pharmaceuticals Limited |
This chapter will help you gain GLOBAL Market Analysis of Niraparib. Further deep in this chapter, you will be able to review Global Niraparib Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Niraparib. Further deep in this chapter, you will be able to review North America Niraparib Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Niraparib. Further deep in this chapter, you will be able to review Europe Niraparib Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Niraparib. Further deep in this chapter, you will be able to review Asia Pacific Niraparib Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Niraparib. Further deep in this chapter, you will be able to review South America Niraparib Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Niraparib. Further deep in this chapter, you will be able to review Middle East Niraparib Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Niraparib. Further deep in this chapter, you will be able to review Middle East Niraparib Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Niraparib. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Niraparib market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 13 Research Methodology and Sources
Why 100mg*30 Capsules have a significant impact on Niraparib market? |
What are the key factors affecting the 100mg*30 Capsules and 100mg*60 Capsules of Niraparib Market? |
What is the CAGR/Growth Rate of Recurrent Epithelial Ovarian Cancer during the forecast period? |
By type, which segment accounted for largest share of the global Niraparib Market? |
Which region is expected to dominate the global Niraparib Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|